Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease - Concepedia

Concepedia

Publication | Open Access

Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease

DOI Full Paper Access

15

Citations

20

References

2021

Year

R Pauwels, Elisa Proietti, C. Janneke van der Woude, Lindsey Oudijk, Marie‐Rose B. S. Crombag, Maikel P. Peppelenbosch, Ursula Grohmann, Gwenny M. Fuhler, Annemarie C. de Vries

Inflammatory Bowel Diseases

Abstract

Tissue levels of VDZ may provide a better marker than serum levels for mucosal inflammation and objective treatment outcome at week 16. The potential of VDZ tissue levels for therapeutic drug monitoring in inflammatory bowel disease warrants further exploration.

References

	Year	Citations

Page 1